Differences in HLA allele frequencies between CeD cases and at-risk controls
| HLA allele | At risk controls % (n = 117) | CeD % (n = 107) | OR (95% CI) | P value |
|---|---|---|---|---|
| B*08:01 | 16.67% | 32.24% | 2.38 (1.52–3.72) | 0.0002 |
| DRB1*03:01 | 22.65% | 36.92% | 1.99 (1.32–3.02) | 0.0010 |
| A*01:01 | 19.66% | 31.78% | 1.91 (1.24–2.94) | 0.0034 |
| DQB1*02:01 | 22.22% | 36.45% | 2.01 (1.33–3.04) | 0.0012 |
| C*07:01 | 20.09% | 30.84% | 1.77 (1.15–2.73) | 0.0092 |
| DQB1*02:02 | 16.81% | 18.87% | 1.15 (0.71–1.87) | 0.6199 |
| DQA1*05:01 | 23.08% | 36.45% | 1.91 (1.27–2.89) | 0.0026 |
| HLA allele | At risk controls % ( | CeD % ( | OR (95% CI) | P value |
|---|---|---|---|---|
| 16.67% | 32.24% | 2.38 (1.52–3.72) | 0.0002 | |
| 22.65% | 36.92% | 1.99 (1.32–3.02) | 0.0010 | |
| 19.66% | 31.78% | 1.91 (1.24–2.94) | 0.0034 | |
| 22.22% | 36.45% | 2.01 (1.33–3.04) | 0.0012 | |
| 20.09% | 30.84% | 1.77 (1.15–2.73) | 0.0092 | |
| 16.81% | 18.87% | 1.15 (0.71–1.87) | 0.6199 | |
| 23.08% | 36.45% | 1.91 (1.27–2.89) | 0.0026 |
Statistical significance was determined by Fisher’s exact test.
Sharing content requires targeting cookies to be enabled. Please update your cookie preferences to use this feature.